查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1713696

2025年全球肿瘤标记检测市场报告

Tumor Marker Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年肿瘤标记检测市场规模将强劲成长。到 2029 年，这一数字将成长至 252.7 亿美元，复合年增长率为 8.0%。预测期内的成长可以归因于人们对癌症早期发现的认识不断提高、癌症研究资金不断增加、个人化医疗的扩展、医疗保健支出的增加以及保险覆盖率的提高。预测期内的关键趋势包括技术进步、产品创新、诊断技术的进步、创新测试解决方案以及策略合作伙伴关係数量的增加。

预计肿瘤标记检测市场的成长将受到癌症盛行率上升的推动。癌症是一种以异常细胞不受控制地生长为特征的疾病，它可以侵入附近的组织并透过血液和淋巴系统扩散到全身。癌症发生率的上升是由于人口老化、环境暴露增加、生活方式改变以及检测和诊断的进步等因素造成的。肿瘤标记测试用于诊断癌症、监测治疗反应或透过测量癌细胞产生的某些物质来检测復发。例如，根据美国癌症协会2023年1月发布的报告，美国癌症新病例1,958,310例，死亡病例609,820例。此外，美国国家医学图书馆于2021年5月预测，到2040年全球癌症病例将达2,840万，比2020年增加47%，并造成大量死亡。此类癌症的发生率不断上升，推动了肿瘤标记检测市场的成长。

为了保持竞争力，肿瘤标记检测市场的公司正专注于开发分子检测解决方案等先进检测。分子检测解决方案是一种先进的诊断方法，透过分析遗传物质（DNA和/或RNA）来在分子层面上检测突变、病原体和特定的生物标记。例如，2024年4月，专注于个人化癌症治疗的瑞士公司RGCC International推出了创新癌症检测测试Onco-D-clare。该测试结合了分子生物学和人工神经网络，能够在症状出现之前及早发现癌症。 Onco-D-clare 从血液样本中分离週边血单核细胞，并对 90 多个基因进行全面的基因表现分析。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球肿瘤标记检测PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球肿瘤标记检测市场：成长率分析
  • 全球肿瘤标记检测市场表现：规模与成长，2019-2024
  • 全球肿瘤标记检测市场预测：规模与成长，2024-2029，2034年
  • 全球肿瘤标记检测总目标市场（TAM）

第六章市场区隔

  • 全球肿瘤标记检测市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 生化标记
  • 致癌基因
  • 生长因子
  • 荷尔蒙
  • 集落刺激因子
  • 淋巴激素
  • 免疫组织化学染色法
  • 其他产品
  • 全球肿瘤标记检测市场（依方法、效能和预测）：2019-2024 年、2024-2029 年、2034 年
  • 筛检
  • 影像学诊断
  • 治疗诊断学
  • 乙状结肠镜检查
  • 其他方法
  • 全球肿瘤标记检测市场：应用、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 医院
  • 商业或私人实验室
  • 医生办公室或团体诊所
  • 癌症诊所
  • 门诊治疗中心
  • 全球肿瘤标记检测市场依生化标记类型、表现及预测细分，2019-2024 年、2024-2029 年、2034 年
  • 胎儿球蛋白（AFP）
  • 前列腺特异性抗原（PSA）
  • 癌胚抗原（CEA）
  • 癌抗原125（CA 125）
  • 癌抗原19-9（CA 19-9）
  • 人类绒毛膜促性腺激素分泌（hCG）
  • 全球肿瘤标记检测市场，依癌症基因类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • HER2/新
  • KRAS
  • BRAF
  • EGFR（表皮生长因子受体）
  • c-MYC
  • p53
  • 全球肿瘤标记检测市场按成长因素类型、表现和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 血管内皮生长因子（VEGF）
  • 血小板衍生生长因子（PDGF）
  • 转化生长因子β（TGF-B）
  • 纤维母细胞生长因子（FGF）
  • 胰岛素样生长因子（IGF）
  • 全球肿瘤标记检测市场依荷尔蒙类型、表现及预测细分，2019-2024 年、2024-2029 年、2034 年
  • 雌激素受体（ER）
  • 孕酮受体（PR）
  • 甲状腺球蛋白
  • 抑钙素
  • 促肾上腺皮质激素（ACTH）
  • 胃泌素
  • 全球肿瘤标记检测市场集落刺激因子细分（按类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 颗粒细胞增生因子（G-CSF）
  • 粒细胞-巨噬细胞集落刺激因子（GM-CSF）
  • 巨噬细胞集落刺激因子（M-CSF）
  • 全球肿瘤标记检测市场按淋巴激素类型、表现和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 白细胞介素-2（IL-2）
  • 干扰素-γ（IFN-Y）
  • 肿瘤坏死因子α（TNF-α）
  • 白细胞介素-6（IL-6）

第七章 区域和国家分析

  • 全球肿瘤标记检测市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球肿瘤标记检测市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 肿瘤标记检测市场：竞争格局
  • 肿瘤标记检测市场：公司简介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Becton Dickinson and Company（BD）
  • Quest Diagnostics Inc.
  • Agilent Technologies Inc
  • Hologic Inc.
  • Illumina Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • DiaSorin SpA
  • Myriad Genetics
  • Ortho Clinical Diagnostics PLC
  • Veracyte Inc.
  • Biodesix Inc.
  • Biocept Inc.
  • Proteomedix AG

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年肿瘤标记检测市场：提供新机会的国家
  • 2029年肿瘤标记检测市场：细分领域带来新机会
  • 2029年肿瘤标记检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r33598

Tumor marker testing involves detecting specific substances, often proteins, that are produced by cancer cells or by the body in response to cancer. These tests are used for diagnosing cancer, monitoring treatment progress, and checking for recurrence. Typically, the tests are conducted on blood, urine, or tissue samples.

Key products in tumor marker testing include biochemical markers, oncogenes, growth factors, hormones, colony-stimulating factors, lymphokines, and immunohistochemical stains, among others. Biochemical markers are measurable substances in the body, such as proteins or enzymes, that indicate biological or pathological processes and are used for diagnosing or tracking diseases. Tumor marker testing is conducted using methods such as screening, imaging, theranostics, and sigmoidoscopy. It is utilized in various settings including hospitals, commercial or private laboratories, physician offices or group practices, cancer clinics, and ambulatory care centers.

The tumor marker testing market research report is one of a series of new reports from The Business Research Company that provides tumor marker testing market statistics, including the tumor marker testing industry's global market size, regional shares, competitors with a tumor marker testing market share, detailed tumor marker testing market segments, market trends and opportunities, and any further data you may need to thrive in the tumor marker testing industry. This tumor marker testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tumor marker testing market size has grown strongly in recent years. It will grow from $17.18 billion in 2024 to $18.6 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to increasing cancer prevalence, rising focus on research and development, rising public awareness of cancer screenings, improved healthcare infrastructure, and an aging population.

The tumor marker testing market size is expected to see strong growth in the next few years. It will grow to $25.27 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to growing awareness of early cancer detection, increasing funding for cancer research, expansion of personalized medicine, increased healthcare expenditure, and improved insurance coverage. Major trends in the forecast period include technological advancements, product innovation, advancement in diagnostic technologies, innovative testing solutions, and increasing strategic collaborations.

The growth of the tumor marker testing market is expected to be driven by the rising prevalence of cancer. Cancer is a disease marked by the uncontrolled growth of abnormal cells that can invade nearby tissues and spread throughout the body via the blood and lymphatic systems. The increase in cancer rates is attributed to factors such as an aging population, greater environmental exposures, lifestyle changes, and advancements in detection and diagnosis. Tumor marker testing is used to diagnose cancer, monitor treatment responses, and detect recurrences by measuring specific substances produced by cancer cells. For example, a report from the American Cancer Society in January 2023 noted that there were 1,958,310 new cancer cases and 609,820 cancer deaths in the United States. Additionally, the National Library of Medicine projected in May 2021 that the global cancer burden would reach 28.4 million cases by 2040, representing a 47% increase from 2020, with a substantial number of deaths. This increasing prevalence of cancer is driving the growth of the tumor marker testing market.

Companies in the tumor marker testing market are focusing on developing advanced tests, such as molecular testing solutions, to stay competitive. Molecular testing solutions are sophisticated diagnostic methods that analyze genetic material (DNA or RNA) to detect mutations, pathogens, or specific biomarkers at a molecular level. For instance, in April 2024, RGCC International GmbH, a Swiss company specializing in personalized cancer treatment, introduced Onco-D-clare, an innovative cancer detection test. This test enables early cancer detection before symptoms appear by combining molecular biology with artificial neural networks. Onco-D-clare isolates peripheral blood mononuclear cells from blood samples and performs a comprehensive gene expression analysis across more than 90 genes.

In June 2023, Quest Diagnostics, a US-based clinical laboratory, acquired Haystack Oncology for $300 million. This acquisition is intended to improve cancer diagnostics by integrating advanced minimal residual disease (MRD) testing technology. Furthermore, it not only enhances Quest's diagnostic capabilities but also seeks to offer more personalized and effective cancer care solutions through innovative liquid biopsy technology. Haystack Oncology is a biotechnology company based in the United States.

Major companies operating in the tumor marker testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche AG, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company (BD), Quest Diagnostics Inc., Agilent Technologies Inc, Hologic Inc., Illumina Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Qiagen N.V., DiaSorin S.p.A., Myriad Genetics, Ortho Clinical Diagnostics PLC, Veracyte Inc., Biodesix Inc., Biocept Inc., Proteomedix AG, OncoCyte Corporation, Biocartis NV

North America was the largest region in the tumor marker testing market in 2024. The regions covered in the tumor marker testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tumor marker testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tumor marker testing market consists of revenues earned by entities by providing services such as genetic testing, prostate-specific antigen (PSA) tests, and dehydrogenase (LDH) tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The tumor marker testing market also includes sales of test kits, instrumentation, consumables, and reagents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tumor Marker Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tumor marker testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tumor marker testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tumor marker testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Biochemical Markers; Oncogenes; Growth Factors; Hormones; Colony Stimulating Factors; Lymphokines; Immunohistochemical Stains; Other Products
  • 2) By Methods: Screening; Imaging; Theranostics; Sigmoidoscopy; Other Methods
  • 3) By Application: Hospitals; Commercial Or Private Laboratories; Physician Offices Or Group Practices; Cancer Clinics; Ambulatory Care Centers
  • Subsegments:
  • 1) By Biochemical Markers: Alpha-fetoprotein (AFP); Prostate-Specific Antigen (PSA); Carcinoembryonic Antigen (CEA); Cancer Antigen 125 (CA 125); Cancer Antigen 19-9 (CA 19-9); Human Chorionic Gonadotropin (hCG)
  • 2) By Oncogenes: HER2/neu; KRAS; BRAF; EGFR (Epidermal Growth Factor Receptor); c-MYC; p53
  • 3) By Growth Factors: Vascular Endothelial Growth Factor (VEGF); Platelet-Derived Growth Factor (PDGF); Transforming Growth Factor-beta (TGF-B); Fibroblast Growth Factor (FGF); Insulin-like Growth Factor (IGF)
  • 4) By Hormones: Estrogen Receptors (ER); Progesterone Receptors (PR); Thyroglobulin; Calcitonin; Adrenocorticotropic Hormone (ACTH); Gastrin
  • 5) By Colony Stimulating Factors: Granulocyte Colony-Stimulating Factor (G-CSF); Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF); Macrophage Colony-Stimulating Factor (M-CSF)
  • 6) By Lymphokines: Interleukin-2 (IL-2); Interferon-gamma (IFN-Y); Tumor Necrosis Factor-alpha (TNF-a); Interleukin-6 (IL-6)
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; F. Hoffmann-La Roche AG; Danaher Corporation; Siemens Healthineers AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tumor Marker Testing Market Characteristics

3. Tumor Marker Testing Market Trends And Strategies

4. Tumor Marker Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Tumor Marker Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Tumor Marker Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Tumor Marker Testing Market Growth Rate Analysis
  • 5.4. Global Tumor Marker Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Tumor Marker Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Tumor Marker Testing Total Addressable Market (TAM)

6. Tumor Marker Testing Market Segmentation

  • 6.1. Global Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biochemical Markers
  • Oncogenes
  • Growth Factors
  • Hormones
  • Colony Stimulating Factors
  • Lymphokines
  • Immunohistochemical Stains
  • Other Products
  • 6.2. Global Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Screening
  • Imaging
  • Theranostics
  • Sigmoidoscopy
  • Other Methods
  • 6.3. Global Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Commercial Or Private Laboratories
  • Physician Offices Or Group Practices
  • Cancer Clinics
  • Ambulatory Care Centers
  • 6.4. Global Tumor Marker Testing Market, Sub-Segmentation Of Biochemical Markers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Alpha-fetoprotein (AFP)
  • Prostate-Specific Antigen (PSA)
  • Carcinoembryonic Antigen (CEA)
  • Cancer Antigen 125 (CA 125)
  • Cancer Antigen 19-9 (CA 19-9)
  • Human Chorionic Gonadotropin (hCG)
  • 6.5. Global Tumor Marker Testing Market, Sub-Segmentation Of Oncogenes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • HER2/neu
  • KRAS
  • BRAF
  • EGFR (Epidermal Growth Factor Receptor)
  • c-MYC
  • p53
  • 6.6. Global Tumor Marker Testing Market, Sub-Segmentation Of Growth Factors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Vascular Endothelial Growth Factor (VEGF)
  • Platelet-Derived Growth Factor (PDGF)
  • Transforming Growth Factor-beta (TGF-B)
  • Fibroblast Growth Factor (FGF)
  • Insulin-like Growth Factor (IGF)
  • 6.7. Global Tumor Marker Testing Market, Sub-Segmentation Of Hormones, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Estrogen Receptors (ER)
  • Progesterone Receptors (PR)
  • Thyroglobulin
  • Calcitonin
  • Adrenocorticotropic Hormone (ACTH)
  • Gastrin
  • 6.8. Global Tumor Marker Testing Market, Sub-Segmentation Of Colony Stimulating Factors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Granulocyte Colony-Stimulating Factor (G-CSF)
  • Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
  • Macrophage Colony-Stimulating Factor (M-CSF)
  • 6.9. Global Tumor Marker Testing Market, Sub-Segmentation Of Lymphokines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Interleukin-2 (IL-2)
  • Interferon-gamma (IFN-Y)
  • Tumor Necrosis Factor-alpha (TNF-a)
  • Interleukin-6 (IL-6)

7. Tumor Marker Testing Market Regional And Country Analysis

  • 7.1. Global Tumor Marker Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Tumor Marker Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tumor Marker Testing Market

  • 8.1. Asia-Pacific Tumor Marker Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tumor Marker Testing Market

  • 9.1. China Tumor Marker Testing Market Overview
  • 9.2. China Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tumor Marker Testing Market

  • 10.1. India Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tumor Marker Testing Market

  • 11.1. Japan Tumor Marker Testing Market Overview
  • 11.2. Japan Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tumor Marker Testing Market

  • 12.1. Australia Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tumor Marker Testing Market

  • 13.1. Indonesia Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tumor Marker Testing Market

  • 14.1. South Korea Tumor Marker Testing Market Overview
  • 14.2. South Korea Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tumor Marker Testing Market

  • 15.1. Western Europe Tumor Marker Testing Market Overview
  • 15.2. Western Europe Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tumor Marker Testing Market

  • 16.1. UK Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tumor Marker Testing Market

  • 17.1. Germany Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tumor Marker Testing Market

  • 18.1. France Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tumor Marker Testing Market

  • 19.1. Italy Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tumor Marker Testing Market

  • 20.1. Spain Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tumor Marker Testing Market

  • 21.1. Eastern Europe Tumor Marker Testing Market Overview
  • 21.2. Eastern Europe Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tumor Marker Testing Market

  • 22.1. Russia Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tumor Marker Testing Market

  • 23.1. North America Tumor Marker Testing Market Overview
  • 23.2. North America Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tumor Marker Testing Market

  • 24.1. USA Tumor Marker Testing Market Overview
  • 24.2. USA Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tumor Marker Testing Market

  • 25.1. Canada Tumor Marker Testing Market Overview
  • 25.2. Canada Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tumor Marker Testing Market

  • 26.1. South America Tumor Marker Testing Market Overview
  • 26.2. South America Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tumor Marker Testing Market

  • 27.1. Brazil Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tumor Marker Testing Market

  • 28.1. Middle East Tumor Marker Testing Market Overview
  • 28.2. Middle East Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tumor Marker Testing Market

  • 29.1. Africa Tumor Marker Testing Market Overview
  • 29.2. Africa Tumor Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Tumor Marker Testing Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Tumor Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tumor Marker Testing Market Competitive Landscape And Company Profiles

  • 30.1. Tumor Marker Testing Market Competitive Landscape
  • 30.2. Tumor Marker Testing Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Tumor Marker Testing Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company (BD)
  • 31.2. Quest Diagnostics Inc.
  • 31.3. Agilent Technologies Inc
  • 31.4. Hologic Inc.
  • 31.5. Illumina Inc.
  • 31.6. bioMerieux SA
  • 31.7. Bio-Rad Laboratories Inc.
  • 31.8. Qiagen N.V.
  • 31.9. DiaSorin S.p.A.
  • 31.10. Myriad Genetics
  • 31.11. Ortho Clinical Diagnostics PLC
  • 31.12. Veracyte Inc.
  • 31.13. Biodesix Inc.
  • 31.14. Biocept Inc.
  • 31.15. Proteomedix AG

32. Global Tumor Marker Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tumor Marker Testing Market

34. Recent Developments In The Tumor Marker Testing Market

35. Tumor Marker Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Tumor Marker Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Tumor Marker Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Tumor Marker Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250423_r33598_Tumor_Marker_Testing_GMR_2025